Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Riera, Marta ^a   Márquez, Eva ^a   Clotet, Sergi ^a   Gimeno, Javier ^a   Roca Ho, Heleia ^a   Lloreta, Josep ^a   Juanpere, Nuria ^a   Batlle, Daniel ^b   Pascual, Julio ^a   Soler, María José ^a  

^a HOSPITAL DEL MAR   (Spain)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN CONVERTING ENZYME 2; INSULIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYMURIA; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MESANGIUM; MOUSE; MOUSE MODEL; NONHUMAN; NONOBESE DIABETIC MOUSE; PODOCYTE; PROTEIN EXPRESSION; URINE LEVEL;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; INSULIN; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MICE; MICE, INBRED NOD; PEPTIDYL-DIPEPTIDASE A;

EID: 84896470332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084683     Document Type: Article

References (51)

1. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, et al. (2009) Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 58: 1201-1211.
2. Mogensen CE, Andersen MJ (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706-712.
3. Zatz R, Meyer TW, Rennke HG, Brenner BM (1985) Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proceedings of the National Academy of Sciences of the United States of America 82: 5963-5967. (Pubitemid 16218883)
4. Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. Journal of the American Society of Nephrology : JASN 15 Suppl 1: S55-57.
5. Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, et al. (1991) Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 324: 1626-1632.
6. Breyer MD, Bottinger E, Brosius FC 3rd, Coffman TM, Harris RC, et al. (2005) Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45. (Pubitemid 43073154)
7. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, et al. (2006) Impact of genetic background on nephropathy in diabetic mice. American journal of physiology Renal physiology 290: F214-222.
8. Soler MJ, Riera M, Batlle D (2012) New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy. Experimental diabetes research 2012: 616313.
9. Wicker LS, Appel MC, Dotta F, Pressey A, Miller BJ, et al. (1992) Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J Exp Med 176: 67-77.
10. He CJ, Zheng F, Stitt A, Striker L, Hattori M, et al. (2000) Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease. Kidney international 58: 1931-1940.
11. Xiao X, Ma B, Dong B, Zhao P, Tai N, et al. (2009) Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice. Journal of autoimmunity 32: 85-93.
12. Raij L (2003) Recommendations for the management of special populations: renal disease in diabetes. Am J Hypertens 16: 46S-49S.
13. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828. (Pubitemid 34670323)
14. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-9.
15. Soler MJ, Wysocki J, Ye M, Lloveras J, Kanwar Y, et al. (2007) ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 72: 614-623. (Pubitemid 47312795)
16. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, et al. (2006) ACE and ACE2 activity in diabetic mice. Diabetes 55: 2132-2139. (Pubitemid 44509989)
17. Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, et al. (2012) Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. Journal of hypertension 30: 375-383.
18. Rosmalen JG, Pigmans MJ, Kersseboom R, Drexhage HA, Leenen PJ, et al. (2001) Sex steroids influence pancreatic islet hypertrophy and subsequent autoimmune infiltration in nonobese diabetic (NOD) and NODscid mice. Laboratory investigation; a journal of technical methods and pathology 81: 231-239.
19. Sturgeon C, Sam AD, 2nd, Law WR (1998) Rapid determination of glomerular filtration rate by single-bolus inulin: a comparison of estimation analyses. Journal of applied physiology 84: 2154-2162. (Pubitemid 28255979)
20. Qi Z, Whitt I, Mehta A, Jin J, Zhao M, et al. (2004) Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. American journal of physiology Renal physiology 286: F590-596. (Pubitemid 38233654)
21. Deb DK, Sun T, Wong KE, Zhang Z, Ning G, et al. (2010) Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney international 77: 1000-1009.
22. Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, et al. (2005) Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. Journal of the American Society of Nephrology : JASN 16: 2953-2966. (Pubitemid 44743493)
23. MacLeod JM, White KE, Tate H, Bilous RW (1997) Efficient morphometric analysis of glomerular mesangium in insulin-dependent diabetic patients with early nephropathy. The European Study of the Progression of Renal Disease in Type 1 (Insulin Dependent) Diabetes (ESPRIT) Study Group. Kidney international 51: 1624-1628. (Pubitemid 27239922)
24. Hirose K, Osterby R, Nozawa M, Gundersen HJ (1982) Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney international 21: 689-695. (Pubitemid 12124298)
25. Jensen EB, Gundersen HJ, Osterby R (1979) Determination of membrane thickness distribution from orthogonal intercepts. Journal of microscopy 115: 19-33. (Pubitemid 10225698)
26. Epelman S, Tang WH, Chen SY, Van Lente F, Francis GS, et al. (2008) Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin- aldosterone system. J Am Coll Cardiol 52: 750-754.
27. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277: 14838-14843. (Pubitemid 34952556)
28. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, et al. (2002) Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347: 797-805. (Pubitemid 34988338)
29. Schmetterer L, Muller M, Fasching P, Diepolder C, Gallenkamp A, et al. (1997) Renal and ocular hemodynamic effects of insulin. Diabetes 46: 1868-1874. (Pubitemid 27456423)
30. Baron AD, Brechtel-Hook G, Johnson A, Hardin D (1993) Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 21: 129-135. (Pubitemid 23035064)
31. Porcellati F, Fanelli C, Bottini P, Epifano L, Rambotti AM, et al. (1993) Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy. Diabetes 42: 1055-1064. (Pubitemid 23182172)
32. Colucci JA, Yuri Arita D, Sousa Cunha T, Seno Di Marco G, Vio CP, et al. (2011) Renin-angiotensin system may trigger kidney damage in NOD mice. Journal of the renin-angiotensin-aldosterone system : JRAAS 12: 15-22.
33. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, et al. (2004) Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 43: 1120-1125. (Pubitemid 38579924)
34. Santos RA, Campagnole-Santos MJ, Andrade SP (2000) Angiotensin-(1-7): an update. Regul Pept 91: 45-62.
35. Stackhouse S, Miller PL, Park SK, Meyer TW (1990) Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats. Diabetes 39: 989-995. (Pubitemid 20233734)
36. Petersen J, Ross J, Rabkin R (1988) Effect of insulin therapy on established diabetic nephropathy in rats. Diabetes 37: 1346-1350. (Pubitemid 19035984)
37. Hale LJ, Hurcombe J, Lay A, Santamaria B, Valverde AM, et al. (2013) Insulin directly stimulates VEGF-A production in the glomerular podocyte. American journal of physiology Renal physiology 305: F182-188.
38. de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, et al. (2011) Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 365: 2366-2376.
39. Batlle D, Jose Soler M, Ye M (2010) ACE2 and diabetes: ACE of ACEs? Diabetes 59: 2994-2996.
40. Batlle D, Soler MJ, Wysocki J (2008) New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy. Curr Opin Nephrol Hypertens 17: 250-257. (Pubitemid 351535927)
41. Batlle D, Wysocki J, Soler MJ, Ranganath K (2012) Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney international 81: 520-528.
42. Soler MJ, Lloveras J, Batlle D (2008) [Angiotensin converting enzyme 2 and its emerging role in the regulation of the renin angiotensin system]. Med Clin (Barc) 131: 230-236.
43. Soler MJ, Wysocki J, Batlle D (2008) Angiotensin-converting enzyme 2 and the kidney. Exp Physiol 93: 549-556. (Pubitemid 351595054)
44. Ye M, Wysocki J, William J, Soler MJ, Cokic I, et al. (2006) Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 17: 3067-3075. (Pubitemid 44707767)
45. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, et al. (2007) Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171: 438-451. (Pubitemid 47344677)
46. Tikellis C, Bialkowski K, Pete J, Sheehy K, Su Q, et al. (2008) ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 57: 1018-1025.
47. Yamaleyeva LM, Gilliam-Davis S, Almeida I, Brosnihan KB, Lindsey SH, et al. (2012) Differential Regulation of Circulating and Renal ACE2 and ACE in Hypertensive mRen2. Lewis Rats with Early Onset Diabetes. American journal of physiology Renal physiology.
48. Zimpelmann J, Kumar D, Levine DZ, Wehbi G, Imig JD, et al. (2000) Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney international 58: 2320-2330.
49. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, et al. (2001) Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney international 60: 957-968. (Pubitemid 34205795)
50. Siu B, Saha J, Smoyer WE, Sullivan KA, Brosius FC 3rd (2006) Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC nephrology 7: 6.
51. Drapeau N, Lizotte F, Denhez B, Guay A, Kennedy CR, et al. (2013) Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes. American journal of physiology Endocrinology and metabolism 304: E1188-1198.